Riociguat in patients with chronic thromboembolic pulmonary hypertension: results from an early access study

BACKGROUND: Following positive results from the Phase III CHEST-1 study in patients with inoperable or persistent/recurrent chronic thromboembolic pulmonary hypertension (CTEPH), the Phase IIIb CTEPH early access study (EAS) was designed to assess the safety and tolerability of riociguat in real-wor...

Descripción completa

Detalles Bibliográficos
Autores principales: McLaughlin, Vallerie V., Jansa, Pavel, Nielsen-Kudsk, Jens E., Halank, Michael, Simonneau, Gérald, Grünig, Ekkehard, Ulrich, Silvia, Rosenkranz, Stephan, Gómez Sánchez, Miguel A., Pulido, Tomás, Pepke-Zaba, Joanna, Barberá, Joan Albert, Hoeper, Marius M., Vachiéry, Jean-Luc, Lang, Irene, Carvalho, Francine, Meier, Christian, Mueller, Katharina, Nikkho, Sylvia, D’Armini, Andrea M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5745920/
https://www.ncbi.nlm.nih.gov/pubmed/29282032
http://dx.doi.org/10.1186/s12890-017-0563-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5745920/
https://www.ncbi.nlm.nih.gov/pubmed/29282032
http://dx.doi.org/10.1186/s12890-017-0563-7

Ejemplares similares